HUM Add to watchlist $305.42 3.28 (-1.06%) Last updated: May 31, 2026 08:37
52-Week Range
$305.42
$163.11 $305.42 $315.66

Fundamentals Overview

Humana Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 32.6 P/B 1.98 P/S 0.27

Intrinsic value (DCF)

+170.8% upside vs price

Profitability

Net margin 0.8%

Risk (Beta)

0.68 — lower vol

Earnings & growth

EPS $9.37 Rev +21.9% Profit +249% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 73% confidence Risk: Lower Volatility — Beta 0.68. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +170.8% upside vs price · Analyst grade: B+ · 3M vs S&P 500: +64.3% · 3M vs Healthcare sector: +78.8%

Pressures (Sell):

Sentiment weakening (3 downgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$36.67B
P/E (TTM)
32.61
EPS (TTM)
$9.37
Dividend Yield
1.16%
52-Week Range
$163.11 - $315.66
Volume vs Avg
N/A
Beta
0.68

About

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eli...
Sector: Healthcare
Headquarters: US
Employees: 65,680
IPO Date: Dec 1981
Beta: 0.68 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 4, Equal Weight: 7, Hold: 5, In Line: 2, Neutral: 6, Outperform: 1, Sector Perform: 2, Sell: 1, Underweight: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $827.23; current price is $305.42. That’s a +170.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 32.61
DCF value (model) $827.23 (170.8% upside)
PEG (TTM) N/A
P/B (TTM) 1.98
P/S (TTM) 0.27
P/FCF (TTM) 28.83
Liquidity & enterprise
Current Ratio (TTM) 1.26
Quick Ratio (TTM) 1.26
Cash Ratio (TTM) 0.23
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 0.82%
Gross margin (TTM) 14.01%
Operating margin (TTM) 1.01%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for HUM.

Analyst Sentiment at a Glance

B+ Sentiment Weakening
Buy 4Equal Weight 7Hold 5In Line 2Neutral 6Outperform 1Sector Perform 2Sell 1Underweight 2
1 upgrade, 3 downgrades
Price Target Consensus
Current $305.42
Median $269.00
Consensus $284.93
Low consensus $195.00
High consensus $441.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Barclays maintain Equal Weight Equal Weight 2026-05-26
UBS maintain Neutral Neutral 2026-05-22
Mizuho maintain Outperform Outperform 2026-05-20
Deutsche Bank upgrade Hold Buy 2026-05-20
Morgan Stanley maintain Underweight Underweight 2026-05-15
Piper Sandler maintain Neutral Neutral 2026-05-13
TD Cowen maintain Hold Hold 2026-05-01
JP Morgan maintain Neutral Neutral 2026-05-01
Guggenheim maintain Buy Buy 2026-04-30
Barclays maintain Equal Weight Equal Weight 2026-04-30
RBC Capital maintain Sector Perform Sector Perform 2026-04-30
UBS maintain Neutral Neutral 2026-04-30
Evercore ISI Group maintain In Line In Line 2026-04-30
Truist Securities maintain Hold Hold 2026-04-30
Truist Securities maintain Hold Hold 2026-04-13
Evercore ISI Group maintain In Line In Line 2026-04-08
Wells Fargo maintain Equal Weight Equal Weight 2026-04-07
Barclays maintain Equal Weight Equal Weight 2026-02-25
Wells Fargo maintain Equal Weight Equal Weight 2026-02-18
Truist Securities maintain Hold Hold 2026-02-17
Goldman Sachs maintain Sell Sell 2026-02-17
TD Cowen maintain Hold Hold 2026-02-13
Cantor Fitzgerald maintain Neutral Neutral 2026-02-12
UBS maintain Neutral Neutral 2026-02-12
Guggenheim maintain Buy Buy 2026-02-12
Jefferies maintain Buy Buy 2026-02-12
RBC Capital downgrade Outperform Sector Perform 2026-02-12
Morgan Stanley downgrade Equal Weight Underweight 2026-02-02
Wells Fargo downgrade Overweight Equal Weight 2026-01-07
Barclays maintain Equal Weight Equal Weight 2026-01-05